US equities
|
NVDA
$237.07
▲+1.33%
SPCX
$165.41
▲+4.06%
MU
$1,059.01
▼-1.48%
TSLA
$376.20
▲+1.52%
MSFT
$527.48
▲+1.92%
INTC
$116.13
▼-2.68%
SNDK
$1,716.65
▼-0.19%
AMD
$627.66
▼-0.99%
NVDA
$237.07
▲+1.33%
SPCX
$165.41
▲+4.06%
MU
$1,059.01
▼-1.48%
TSLA
$376.20
▲+1.52%
MSFT
$527.48
▲+1.92%
INTC
$116.13
▼-2.68%
SNDK
$1,716.65
▼-0.19%
AMD
$627.66
▼-0.99%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Checkpoint Therapeutics, Inc. - Common Stock
(NQ:
CKPT
)
4.260
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Checkpoint Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Mid-Morning Market Update: Markets Mixed; Campbell Soup Profit Misses Views
↗
June 09, 2021
Following the market opening Wednesday, the Dow traded down 0.02% to 34,592.56 while the NASDAQ rose 0.19% to 13,951.02. The S&P also rose, gaining 0.04% to 4,229.15. The U.S...
Via
Benzinga
Topics
Stocks
Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2021
↗
June 09, 2021
Upgrades According to Deutsche Bank, the prior rating for KLA Corp (NASDAQ:KLAC) was changed from Hold to Buy. KLA earned $3.85 in the third quarter, compared to $2.47 in...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
June 09, 2021
Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 248.41% to $7.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $93.4...
Via
Benzinga
28 Stocks Moving in Wednesday's Pre-Market Session
↗
June 09, 2021
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) rose 72.4% to $3.81 in pre-market trading following Zacks article 'AEMD: First Ever In Vivo Removal Of COVID Virus From...
Via
Benzinga
Diversifying to Conquer: Fortress Biotech (FBIO) Partnering Expansion Driving Progress in Cancer Immunotherapy and Rare Disease Therapeutics
↗
June 03, 2021
The following article is sponsored by the clinical communications unit of Redington, Inc. The information contained in this article in no way represents investment advice or...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >